G01N 33/746
Erythropoetin
Official title: {Erythropoetin}
G01N33/746 (Erythropoetin) appears on 32 US grants and 60 published applications in this corpus.
Search patents in G01N- Granted patents
- 32
- Published applications
- 60
- Assignees
- 36
- Inventors
- 120
- Latest grant
- 23 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 4 |
| 2004 | 0 | 4 |
| 2005 | 0 | 2 |
| 2006 | 2 | 8 |
| 2007 | 2 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 4 |
| 2012 | 2 | 5 |
| 2013 | 3 | 7 |
| 2014 | 2 | 3 |
| 2015 | 2 | 4 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers23 Nov 2021US 11,181,523 B2Universidad De Chile
- Antibodies to human erythroferrone and uses thereof12 Oct 2021US 11,142,572 B2Intrinsic Lifesciences LLC
- Antibodies to human erythroferrone and uses thereof31 Mar 2020US 10,604,567 B2Intrinsic Lifesciences LLC
- Methods and compositions related to modulators of eukaryotic cells3 Dec 2019US 10,494,438 B2The Scripps Research Institute
- Signal biomarkers12 Jun 2018US 9,994,631 B2Upstream Medical Technologies Limited
- Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylase2 Dec 2021US 2021/0369702 A1FibroGen, Inc.
- Use of the basic form of recombinant human erythropoietin in the treatment of a patients with spinocerebellar ataxia with cag repeat mutations4 Mar 2021US 2021/0060127 A1Centro De Inmunologia Molecular
- Antibodies to human erythroferrone and uses thereof23 Jul 2020US 2020/0231668 A1Intrinsic Lifesciences LLC
- Use of Antibodies to TIMP-2 for the Improvement of Renal Function29 Aug 2019US 2019/0263926 A1Astute Medical, Inc.
- Signal biomarkers4 Apr 2019US 2019/0100576 A1Upstream Medical Technologies Limited
Most cited
By later US patents
- Small molecule mimetics of erythropoietin31US 5,835,382 AThe Scripps Research Institute · 1998
- Radioimmunoassay for erythropoietin24US 4,254,095 AResearch Corporation · 1981
- Methods for identifying erythropoietin receptor binding protein21US 6,221,608 B1Ortho Pharmaceutical Corporation · 2001
- A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin20US 4,558,006 AKirin-Amgen, Inc. · 1985
- Monoclonal anti-erythropoietin18US 4,558,005 AUniversity Patents, Inc. · 1985